Nang Kuang Partners with Orion to Commercialize Patented Inhalation Products in Mainland China Market
In December 2022, Nang Kuang has entered into a long-term exclusive licensing partnership with Orion Corporation（Orion）for the commercialization of Budesonide Inhalation Powder and Salbutamol Sulfate Inhalation Powder.
Orion is a globally operating Finnish pharmaceutical company founded in 1917. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is a market leader in Finland. Its head office is established in Espoo, Finland. It has sales companies and representative offices in 26 countries in Europe.
Orion continuously develops new drugs and treatment methods. The core therapy areas of pharmaceutical R&D are oncology, pain and respiratory diseases for which Orion develops inhaled Easyhaler® pulmonary drugs. Finland leads the world in asthma treatment. With Easyhaler, Orion has made a significant contribution to Finland’s success.
For more information, visit www.nangkuang-med.com